Dynamic contrast-enhanced MRI in the differentiation of breast tumors: User-defined versus semi-automated region-of-interest analysis

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 6, 1999, Pages 945-949

  Liney, Gary P ^a,c   Gibbs, Peter ^a   Hayes, Carmel ^b   Leach, Martin O ^b   Turnbull, Lindsay W ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Breast; Dynamic contrast enhanced MRI; Region of interest

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER SCREENING; CONTRAST ENHANCEMENT; FEMALE; HUMAN; IMAGE DISPLAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; SCLEROSIS;

EID: 0032722586     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199912)10:6<945::AID-JMRI6>3.0.CO;2-I     Document Type: Article

References (21)

1. Feig SA. Decreased breast cancer mortality through mammographic screening: results of clinical trials. Radiology 1988; 167:659-665.
2. Ciatto S, Cataliott L, Distante V. Non-palpable lesions detected by mammography: review of 512 consecutive cases. Radiology 1987; 165:92-102.
3. Heywang SH, Hahn D, Schmidt H. MR Imaging of the breast using Gd-DTPA. J Comput Assist Tomogr 1986;10:615-620.
4. Oellinger H, Heins S, Sander B. Gd-DTPA enhanced MR breast imaging: the most sensitive method for multicentric carcinomas of the female breast. Eur Radiol 1993;3:223-226.
5. Greenstein-Orel S, Schnall MD, Powell CM. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995;196:115-122.
6. Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: findings at gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995;197: 387-395.
7. Kelcz F, Santyr GE, Cron GO, Mongin SJ. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI. J Magn Reson Imaging 1996;6:743-752.
8. Kerslake RW, Carleton PJ, Fox JN. Dynamic gradient-echo and fat suppressed spin-echo contrast-enhanced MRI of the breast. Clin Radiol 1995;50:440-454.
9. Teubner JK, Peiotgen H, Dorn T, et al. Dynamic versus static analysis in contrast enhanced MR imaging of the breast. Radiology 1997;205:96
10. Den Boer JA, Hoendrop RKKM, Smink J, et al. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions. J Magn Reson Imaging 1997;7:702-715.
11. Sinha S, Lucas-Quesada RA, DeBruhl ND, et al. Multifeature analysis of Gd-enhanced MR images of breast lesions. J Magn Reson Imaging 1997;7:1016-1026.
12. Muller-Schimpfle M, Ohmenhauser K, Sand J, Stoll P, Claussen CD. Dynamic MR mammography: is there a benefit of a sophisticated evaluation of enhancement curves? In: Proceedings of the Society for Magnetic Resonance in Medicine Third Annual Meeting, 1995, 3:1603.
13. Heywangkobrunner SH, Hausten J, Pohl C, et al. Contrast-enhanced MR-imaging of the breast: comparison of 2 different doses of gadopentetate dimeglumine. Radiology 1994: 191:639-646.
14. Kaiser WA. MR mammography (MRM). Berlin: Springer-Verlag; 1993. pp 37-88.
15. Aronen HJ, Gazit IE, Louis DN. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51.
16. Gribbestad IS, Nilsen G, Fjosne HE, et al. Comparitive signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging 1994;4:477-480.
17. National multi-centre study of MRI screening in women at genetic risk of breast cancer. Lancet 1997;http://www.thelancet.com/ newlancet/reg/ author/protocol7_4.html
18. Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast-enhanced MRI. Magn Reson Imaging 1993;11:617.
19. Frouge C, Guinebretiere J, Contesso G. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994;29:1043-1049.
20. Mussarakis S, Buckley DL, Horsman A. Dynamic MRI of invasive breast cancer: assessment of three region-of-interest analysis methods. J Comput Assist Tomogr 1997;21:431-438.
21. Mussarakis S, Gibbs P, Horsman A. Primary breast abnormalities: selective pixel sampling on dynamic gadolinium-enhanced MR images. Radiology 1998;206:465-473.